Company Performance: Strong earnings reports, positive clinical trial results, and successful drug launches typically drive the stock price higher.

Market Sentiment: Overall market conditions and investor confidence can influence the demand for LLY.STU shares, impacting its price.

Drug Pipeline: The progress and potential of Eli Lilly's drug development pipeline significantly affect investor expectations and the stock's valuation.

Competition: The emergence of competing drugs or therapies can put downward pressure on LLY.STU's price, especially for key revenue-generating products.

Regulatory Approvals: Approval or rejection of new drugs by regulatory agencies like the FDA has a direct and often immediate impact on the stock price.

Economic Conditions: Broad economic factors, such as interest rates and inflation, can influence investor behavior and the attractiveness of pharmaceutical stocks.

Patent Expiration: The loss of patent protection for major drugs can lead to generic competition and reduced revenue, negatively affecting the stock price.

Analyst Ratings: Upgrades or downgrades by financial analysts can influence investor perception and trading activity, impacting the stock price.